Literature DB >> 28884949

Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes.

Thomas Nyström1,2, Martin J Holzmann3,4, Björn Eliasson5, Ann-Marie Svensson6, Ulrik Sartipy7,8.   

Abstract

AIMS: This study aimed to investigate the association between insulin resistance as determined by the estimated glucose disposal rate (eGDR), and survival in adults with type 1 diabetes (T1D) in Sweden.
MATERIAL AND METHODS: Using the Swedish National Diabetes Register, indviduals with T1D were included from January 1, 2005 to December 31, 2012. Outcomes were retrieved from National healthcare registers. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for the associations between eGDR (mg/kg/min) categorized into <4, 4 to 5.99, 6 to 7.99, and ≥8 (reference) and outcomes. Relative survival methods were used to compare survival to a matched Swedish reference population.
RESULTS: Among 17 050 included individuals with T1D, 10.5%, 20.2%, 20.5% and 48.9% had an eGDR of <4, 4 to 5.99, 6 to 7.99, and ≥8, respectively. Individuals with an eGDR <8 were older and had more comorbidities. During a median follow-up of 7.1 years, there were 946 (6%) deaths; 264 (15%), 367 (11%), 195 (6%) and 120 (1%) deaths occurred in individuals with an eGDR of <4, 4 to 5.99, 6 to 7.99 and ≥8, respectively. After adjustment for a wealth of different covariates including diabetes duration, age, sex and renal function, individuals with an eGDR <4, 4 to 5.99, and 6 to 7.99 had an increased risk of death compared to those with an eGDR ≥8 (adjusted HRs, 95% CIs, P values: 2.78, 2.04 to 3.77, <.001; 1.92, 1.49 to 2.46, <.001; 1.73, 1.34 to 2.21, <.001). Survival in individuals with an eGDR ≥8 was equal to a matched general population.
CONCLUSIONS: There is a strong association between eGDR and all-cause mortality, as well as cardiovascular mortality, in individuals with T1D. Our findings may guide preventive measures by improving risk assessment in individuals with T1D.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  diabetes complications; insulin resistance; observational study; type 1 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28884949     DOI: 10.1111/dom.13110

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  16 in total

1.  Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes.

Authors:  Ruchi Jain; Türküler Özgümüş; Troels Mygind Jensen; Elsa du Plessis; Magdalena Keindl; Cathrine Laustrup Møller; Henrik Falhammar; Thomas Nyström; Sergiu-Bogdan Catrina; Gun Jörneskog; Leon Eyrich Jessen; Carol Forsblom; Jani K Haukka; Per-Henrik Groop; Peter Rossing; Leif Groop; Mats Eliasson; Björn Eliasson; Kerstin Brismar; Mahmoud Al-Majdoub; Peter M Nilsson; Marja-Riitta Taskinen; Ele Ferrannini; Peter Spégel; Tore Julsrud Berg; Valeriya Lyssenko
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

2.  Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data.

Authors:  Diana Šimonienė; Aksana Platūkiene; Edita Prakapienė; Lina Radzevičienė; Džilda Veličkiene
Journal:  Diabetes Ther       Date:  2019-12-02       Impact factor: 2.945

3.  Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.

Authors:  Giuseppe Penno; Anna Solini; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Gianpaolo Zerbini; Olga Lamacchia; Antonio Nicolucci; Giuseppe Pugliese
Journal:  BMC Med       Date:  2021-03-15       Impact factor: 8.775

4.  Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study.

Authors:  Revathi Nishtala; Noppadol Kietsiriroje; Mohammad Karam; Ramzi A Ajjan; Sam Pearson
Journal:  Diab Vasc Dis Res       Date:  2020 May-Jun       Impact factor: 3.291

5.  Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139-e141.

Authors:  Monia Garofolo; Elisa Gualdani; Cristina Bianchi; Michele Aragona; Fabrizio Campi; Daniela Lucchesi; Giuseppe Daniele; Roberto Miccoli; Paolo Francesconi; Stefano Del Prato; Giuseppe Penno
Journal:  Diabetes Care       Date:  2021-04       Impact factor: 19.112

6.  The association between overweight/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study.

Authors:  Nathan Wp Cantley; Kathryn Lonnen; Ioannis Kyrou; Abd A Tahrani; Hassan Kahal
Journal:  BMC Endocr Disord       Date:  2021-09-16       Impact factor: 2.763

Review 7.  Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis.

Authors:  Mark Lambie; Mario Bonomini; Simon J Davies; Domenico Accili; Arduino Arduini; Victor Zammit
Journal:  Trends Endocrinol Metab       Date:  2021-07-12       Impact factor: 10.586

8.  Comparison of indirect markers of insulin resistance in adult patients with Double Diabetes.

Authors:  Aldo Ferreira-Hermosillo; Raúl Ibarra-Salce; Joshua Rodríguez-Malacara; Mario Antonio Molina-Ayala
Journal:  BMC Endocr Disord       Date:  2020-06-15       Impact factor: 2.763

9.  Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.

Authors:  Antonio J Amor; Esmeralda Castelblanco; Marta Hernández; Marga Gimenez; Minerva Granado-Casas; Jesús Blanco; Berta Soldevila; Enric Esmatjes; Ignacio Conget; Nuria Alonso; Emilio Ortega; Didac Mauricio
Journal:  Cardiovasc Diabetol       Date:  2020-08-09       Impact factor: 9.951

10.  Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study.

Authors:  Monia Garofolo; Elisa Gualdani; Maria Giovanna Scarale; Cristina Bianchi; Michele Aragona; Fabrizio Campi; Daniela Lucchesi; Giuseppe Daniele; Roberto Miccoli; Paolo Francesconi; Stefano Del Prato; Giuseppe Penno
Journal:  Diabetes Care       Date:  2020-08-13       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.